Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04066699 · ClinicalTrials.gov registry record
Percutaneous Localization: Open-label Registry of Thoracic Surgery
A clinical trial, sponsored by Veran Medical Technologies.
- Completed
- Registry status
- 70
- Enrollment target
NCT04066699: Completed study, sponsored by Veran Medical Technologies.
NCT04066699 is a clinical trial that has completed, run by Veran Medical Technologies. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04066699 has completed, sponsored by Veran Medical Technologies.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
Study Summary
The objectives of this study are to evaluate intraoperative percutaneous lung lesion marking assisted by electromagnetic guided percutaneous navigation and related tools.
Primary Outcome
Successful percutaneous localization of PPN defined as the percentage of subjects in whom the nodule is successfully localized and removed in the first resected specimen.
Interventions
- PROCEDURE Percutaneous localization of suspicious lung lesion(s) using electromagnetic navigation and tools.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2019-10-10 |
| Est. Completion | 2023-02-09 |
What the finished NCT04066699 record still lists
NCT04066699 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 70 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Percutaneous localization of suspicious lung lesion(s) using electromagnetic navigation and tools. is the first listed.
NCT04066699 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04066699 about?
NCT04066699 is a clinical study titled "Percutaneous Localization: Open-label Registry of Thoracic Surgery". The objectives of this study are to evaluate intraoperative percutaneous lung lesion marking assisted by electromagnetic guided percutaneous navigation and related tools.
What is the current status of trial NCT04066699?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2019-10-10. Estimated completion is 2023-02-09.
What interventions are being tested in trial NCT04066699?
The interventions under investigation include: Percutaneous localization of suspicious lung lesion(s) using electromagnetic navigation and tools. (PROCEDURE).
Who is sponsoring clinical trial NCT04066699?
This trial is sponsored by Veran Medical Technologies, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI